XT
MYGN icon

XTX Topco’s Myriad Genetics MYGN Stock Holding History

XTX Topco’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$470K Buy
+104,368
New +$544K 0.01% 2104
2025
Q3 		– Sell
-284,357
Closed -$1.51M – 3025
2025
Q2 		$1.51M Buy
284,357
+263,147
+1,241% +$1.55M 0.06% 451
2025
Q1 		$188K Sell
21,210
-42,870
-67% -$515K 0.01% 1717
2024
Q4 		$879K Buy
64,080
+52,923
+474% +$977K 0.07% 374
2024
Q3 		$306K Sell
11,157
-1,370
-11% -$37.1K 0.02% 1168
2024
Q2 		$306K Buy
+12,527
New +$275K 0.03% 948
2023
Q3 		– Sell
-9,825
Closed -$228K – 1850
2023
Q2 		$228K Buy
+9,825
New +$214K 0.04% 924
2021
Q2 		– Sell
-9,974
Closed -$304K – 995
2021
Q1 		$304K Buy
+9,974
New +$283K 0.15% 267

Other funds holding MYGN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

XTX Topco's MYGN Position: Q1 2026 in Review

XTX Topco opened a new position in Myriad Genetics (MYGN) in Q1 2026: 104,368 shares worth $470K. The stake represents 0.01% of the portfolio and ranks #2104 among its holdings. This is a return to the name: XTX Topco previously reported a position in MYGN as recently as Q2 2025.

XTX Topco first reported a position in MYGN in Q1 2021 and has held it in 8 quarters since. The position peaked at $1.51M in Q2 2025. 202 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.

  • XTX Topco held 104,368 shares of Myriad Genetics worth $470K as of Q1 2026.
  • Myriad Genetics was a new XTX Topco position in Q1 2026.
  • Myriad Genetics made up 0.01% of XTX Topco's portfolio in Q1 2026, its #2104 holding.
  • XTX Topco first reported a position in Myriad Genetics in Q1 2021 and has held it in 8 quarters since.
  • XTX Topco's Myriad Genetics position peaked at $1.51M in Q2 2025.
  • 202 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.